Cervical Cancer During Pregnancy: Difference between revisions
No edit summary |
Nima Nasiri (talk | contribs) No edit summary |
||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cervical cancer}} | {{Cervical cancer}} | ||
{{CMG}}{{AE}}{{MD}} | {{CMG}}{{AE}}{{Nnasiri}}{{MD}} | ||
==Overview== | |||
There is no therapy recommended for preinvasive lesions of the cervix, including carcinoma in situ, during pregnancy, but colposcopy can be done to rule out invasive cancer. Patients with early stage (IA) disease may safely undergo fertility-sparing treatments. For patients with advanced disease, waiting for viability is generally not acceptable.The standard of care is curative intent chemotherapy and radiation therapy. | |||
==Cervical Cancer During Pregnancy== | ==Cervical Cancer During Pregnancy== | ||
During pregnancy, no therapy is warranted for preinvasive lesions of the cervix, including carcinoma in situ, although expert colposcopy is recommended to exclude invasive cancer. | During [[pregnancy]], no therapy is warranted for preinvasive lesions of the cervix, including carcinoma in situ, although expert [[colposcopy]] is recommended to exclude invasive cancer. | ||
<ref>http://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq#section/_798</ref> | <ref>http://www.cancer.gov/types/cervical/hp/cervical-treatment-pdq#section/_798</ref> | ||
===Diagnosis=== | ===Diagnosis=== | ||
Treatment of cervical cancer in pregnancy is predicated on the extent of disease and the gestational age at diagnosis. Patients should undergo biopsy as needed and imaging to establish the extent of disease to make the most informed choices. The most appropriate imaging modality in pregnancy is magnetic resonance imaging, when indicated. | Treatment of cervical cancer in [[pregnancy]] is predicated on the extent of disease and the gestational age at diagnosis. Patients should undergo biopsy as needed and imaging to establish the extent of disease to make the most informed choices. The most appropriate imaging modality in [[pregnancy]] is magnetic resonance imaging, when indicated. | ||
===Treatment for Stage I Disease=== | ===Treatment for Stage I Disease=== | ||
Pregnancy does not alter the course of cervical cancer. As a result, in certain cases, patients may elect to postpone treatment until its effects on the pregnancy are minimized. This may be considered for patients with the more common, and less aggressive histologic subtypes: squamous, adenocarcinoma, and adenosquamous. Patients with high-risk subtypes, such as small cell or neuroendocrine tumors, should be counseled toward immediate treatment despite the effects on the fetus, given their risk of progression. | [[Pregnancy]] does not alter the course of cervical cancer. As a result, in certain cases, patients may elect to postpone treatment until its effects on the [[pregnancy]] are minimized. This may be considered for patients with the more common, and less aggressive histologic subtypes: [[squamous]], [[adenocarcinoma]], and adenosquamous. Patients with high-risk subtypes, such as small cell or neuroendocrine tumors, should be counseled toward immediate treatment despite the effects on the fetus, given their risk of progression. | ||
Patients with early stage (IA) disease may safely undergo fertility-sparing treatments including cervical conization or radical trachelectomy, as indicated. The optimal timing for this procedure is in the second trimester, before viability. Some authors have suggested waiting until the completion of a pregnancy to initiate treatment.For patients with IA2 and IB disease such a delay may also be safe, but because of a risk of lymphatic spread, assessment of lymph-node status should first be ascertained. The status is best determined surgically via a laparoscopic or open lymph-node dissection, which can be safely performed up to approximately 20 weeks of pregnancy.In patients without lymphatic spread, waiting for fetal viability to initiate treatment is an option. Patients with positive lymph nodes should be counseled toward immediate treatment. | Patients with early stage (IA) disease may safely undergo fertility-sparing treatments including cervical [[conization]] or radical [[trachelectomy]], as indicated. The optimal timing for this procedure is in the second trimester, before viability. Some authors have suggested waiting until the completion of a [[pregnancy]] to initiate treatment.For patients with IA2 and IB disease such a delay may also be safe, but because of a risk of lymphatic spread, assessment of lymph-node status should first be ascertained. The status is best determined surgically via a laparoscopic or open lymph-node dissection, which can be safely performed up to approximately 20 weeks of [[pregnancy]].In patients without lymphatic spread, waiting for fetal viability to initiate treatment is an option. Patients with positive lymph nodes should be counseled toward immediate treatment. | ||
===Treatment for Stages II, III, and IV Disease=== | ===Treatment for Stages II, III, and IV Disease=== | ||
For patients with stage II or greater disease, waiting for viability is generally not acceptable.The standard of care is curative intent chemotherapy and radiation therapy. This treatment is toxic to the fetus and without ovarian transposition will render the ovaries nonfunctional after treatment. Evacuation of the fetus should be performed before the initiation of radiation. When this is not possible, the radiation will generally cause a spontaneous abortion 3 to 5 weeks after initiating treatment. | For patients with stage II or greater disease, waiting for viability is generally not acceptable.The standard of care is curative intent [[chemotherapy]] and [[radiation therapy]]. This treatment is toxic to the fetus and without [[ovarian]] transposition will render the ovaries nonfunctional after treatment. Evacuation of the fetus should be performed before the initiation of radiation. When this is not possible, the radiation will generally cause a spontaneous abortion 3 to 5 weeks after initiating treatment. | ||
===Neoadjuvant chemotherapy=== | |||
Neoadjuvant [[chemotherapy]] has been offered to patients with locally advanced disease as a way to initiate treatment while maintaining the [[pregnancy]]. Most [[chemotherapy]] agents can be initiated safely in the second trimester of [[pregnancy]] and beyond; mild growth restriction of the fetus is the most common side effect. Restriction of growth has been reported in a relatively small number of patients, and data is lacking on long-term outcomes for these women; as a result, this strategy should be considered with caution. Most of the patients in the reports underwent standard treatment (either surgery or radiation) after completion of the [[pregnancy]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 26: | Line 29: | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gynecology]] | |||
Latest revision as of 15:01, 19 February 2019
|
Cervical cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cervical Cancer During Pregnancy On the Web |
|
American Roentgen Ray Society Images of Cervical Cancer During Pregnancy |
|
Risk calculators and risk factors for Cervical Cancer During Pregnancy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]Monalisa Dmello, M.B,B.S., M.D. [3]
Overview
There is no therapy recommended for preinvasive lesions of the cervix, including carcinoma in situ, during pregnancy, but colposcopy can be done to rule out invasive cancer. Patients with early stage (IA) disease may safely undergo fertility-sparing treatments. For patients with advanced disease, waiting for viability is generally not acceptable.The standard of care is curative intent chemotherapy and radiation therapy.
Cervical Cancer During Pregnancy
During pregnancy, no therapy is warranted for preinvasive lesions of the cervix, including carcinoma in situ, although expert colposcopy is recommended to exclude invasive cancer. [1]
Diagnosis
Treatment of cervical cancer in pregnancy is predicated on the extent of disease and the gestational age at diagnosis. Patients should undergo biopsy as needed and imaging to establish the extent of disease to make the most informed choices. The most appropriate imaging modality in pregnancy is magnetic resonance imaging, when indicated.
Treatment for Stage I Disease
Pregnancy does not alter the course of cervical cancer. As a result, in certain cases, patients may elect to postpone treatment until its effects on the pregnancy are minimized. This may be considered for patients with the more common, and less aggressive histologic subtypes: squamous, adenocarcinoma, and adenosquamous. Patients with high-risk subtypes, such as small cell or neuroendocrine tumors, should be counseled toward immediate treatment despite the effects on the fetus, given their risk of progression. Patients with early stage (IA) disease may safely undergo fertility-sparing treatments including cervical conization or radical trachelectomy, as indicated. The optimal timing for this procedure is in the second trimester, before viability. Some authors have suggested waiting until the completion of a pregnancy to initiate treatment.For patients with IA2 and IB disease such a delay may also be safe, but because of a risk of lymphatic spread, assessment of lymph-node status should first be ascertained. The status is best determined surgically via a laparoscopic or open lymph-node dissection, which can be safely performed up to approximately 20 weeks of pregnancy.In patients without lymphatic spread, waiting for fetal viability to initiate treatment is an option. Patients with positive lymph nodes should be counseled toward immediate treatment.
Treatment for Stages II, III, and IV Disease
For patients with stage II or greater disease, waiting for viability is generally not acceptable.The standard of care is curative intent chemotherapy and radiation therapy. This treatment is toxic to the fetus and without ovarian transposition will render the ovaries nonfunctional after treatment. Evacuation of the fetus should be performed before the initiation of radiation. When this is not possible, the radiation will generally cause a spontaneous abortion 3 to 5 weeks after initiating treatment.
Neoadjuvant chemotherapy
Neoadjuvant chemotherapy has been offered to patients with locally advanced disease as a way to initiate treatment while maintaining the pregnancy. Most chemotherapy agents can be initiated safely in the second trimester of pregnancy and beyond; mild growth restriction of the fetus is the most common side effect. Restriction of growth has been reported in a relatively small number of patients, and data is lacking on long-term outcomes for these women; as a result, this strategy should be considered with caution. Most of the patients in the reports underwent standard treatment (either surgery or radiation) after completion of the pregnancy.